NewsRamp Health & Wellness Podcast

Jessica Owens, a veteran venture investor and founder, brings over 20 years of experience to iOrganBio, aiding in the advancement of AI-driven cell manufacturing with a focus on predictability and scalability.

Strawberry Fields REIT excels in Q1, DOJ targets health fraud, AI aids early cancer detection, companies unveil innovative solutions, and research breakthroughs in various health sectors.

Updates on AI Maverick Intel, SS Innovations International, Aclarion, stroke recognition, CNS Pharmaceuticals, NanoViricides, breast cancer research, HealthLynked Corp., and Ventripoint Diagnostics Ltd.

Discover how Cardio Diagnostics Holdings leverages AI for heart disease detection, while learning the importance of stroke awareness and recognizing the signs.

Explore cutting-edge developments in precision medicine, dental care, pharmaceutical advancements, and AI-driven technologies in the healthcare industry.

Various dental and surgical practices in multiple locations announce expansions, new services, and strategic appointments to meet the growing demand for specialized healthcare.

Companies like Cardio Diagnostics and LIXTE Biotechnology are leveraging AI and precision therapies to advance cardiovascular disease detection, cancer treatments, and eye health. Additionally, research highlights potential breakthroughs in glioblastoma treatment and the link between heart, kidney, metabolic conditions, and cancer risk.

Explore groundbreaking initiatives in precision cancer treatment by LIXTE Biotechnology Holdings, AI-driven healthcare solutions by HeartBeam, and more cutting-edge advancements in the healthcare industry.

Aclarion, Inc. announces stock repurchase plan to boost Nociscan adoption. ActiPatch® launches in Taiwan with BioElectronics Corporation partnering. Study reveals high blood pressure rates in post-9/11 U.S. veterans.

Soligenix focuses on patient-centric reformulation strategies, while other biotechs emphasize capital discipline, diversified pipelines, and novel treatments for conditions like global measles and CNS tumors.

BioXgen invites investors to a live webinar on April 30, 2026, showcasing its breakthrough cardiac patch to address postoperative atrial fibrillation in open-heart surgery patients.

Cardio Diagnostics Holdings integrates epigenetics, genetics, and AI; Soligenix receives orphan drug designation for Behçet’s disease; Oragenics progresses in Phase IIa concussion therapy trial; Aditxt's precision oncology subsidiary showcases predictive assays; and Ocumetics reports improved vision results.

Biotech companies like Oncotelic Therapeutics Inc. demonstrate how scientific progress in drug pipelines is now seen as a financial asset, shaping financial strategies in the industry.

Lixte Biotechnology leads with LB-100 in combination therapies for solid tumors. HeartBeam's $10M funding boosts cardiac tech. Soligenix makes strides in CTCL research.

Soligenix Inc. is utilizing synthetic hypericin for dermatologic treatments, while a new breakthrough in Glioblastoma treatment offers hope for patients.

GeoVax Labs tackles orthopoxvirus vaccine challenges, Aclarion receives AI award for back pain solution, NeuroOne's stock split, LIXTE reports cancer trial results, Stanford's urine test for bladder cancer, and more updates in medical technologies.

NRx Pharmaceuticals prepares for ketamine product approval with new CCO, Catalyst Crew Technologies aligns patents with subsidiary, and VectorCertain achieves 100% success in preventing unsanctioned AI agent scope expansion.

Lixte Biotech enhances cancer treatment with LB-100, while Annovis Bio secures funding for Phase 3 trials. Nightfood Holdings pioneers AI-enabled robotics in drug manufacturing, with Lixte Biotech and health insurers also making significant strides in the healthcare industry.

Lixte Biotech Holdings and Nightfood Holdings are pioneering precision oncology treatments and AI-enabled robotics in drug manufacturing, while Sakowitz Smiles Orthodontics revolutionizes orthodontic care with innovative technology.

Learn how to save on dental implants with Affordable Dental Marketing's comprehensive guide covering cost breakdowns, bundle deals, financing options, and alternative treatment approaches.

Learn about AI-driven lung disease detection, vitamin B3 for brain cancer, financing for clinical trials, rare disease drug designation, and advancements in dental and orthodontic care.

United Health Products, Inc. receives FDA approval for a new clinical study and collaborates with a U.S. partner for exclusive rights, while also undergoing a GCP audit following CEO's optimistic update on progress.

Nurse-led cosmetic injectables in Manly, Monokian Dentistry's patient-centered care in Haddonfield and Marlton, and concerns about healthcare affordability in America. Orthodontic Specialists rebranding in Souderton and Quakertown.

Orthodontic Specialists rebrands for better care, Biohacking Index spotlights women in health, Okuda Orthodontics offers family services, OMRON Healthcare partners with UCSF for AFib study, TibaRay revolutionizes cancer treatment.

Ezalife's Button Huggie® reduces feeding tube dislodgement; NeuroOne grants equity award; Soligenix publishes positive study results; various dental clinics offer advanced care; LIXTE Biotechnology focuses on oncology therapies.

Soligenix's HyBryte shows promise for cutaneous T-cell lymphoma, NurExone Biologic wins award and plans investor outreach, CIRM celebrates FDA approval of KRESLADI™, GeoVax Labs' MVA-X vaccine offers durable protection, and Sigyn Therapeutics evaluates technologies for CTE in former NFL players.

Discover advancements in precision cardiovascular medicine, cancer treatment, rare disease therapies, and preventive oral care. Explore transformative technologies, clinical trials, financial milestones, and strategic partnerships in the biotech and healthcare sectors.

A $20M initiative targets single ventricle heart disease care, a pharmacy professional partners with CMP, thymus impacts cancer immunotherapy, companies announce financial progress, and AI Maverick Intel plans to acquire HEAL Access Canada Inc. SS Innovations expands globally, and the American Heart Association emphasizes the importance of physical activity for heart health.

10X Health appoints Jeff Zwiefel to drive global growth in personalized health solutions, while Ezalife experiences early success with its feeding tube product and equity crowdfunding campaign.

Forian Inc. sees revenue growth, Lixte Biotech advances precision oncology, Aptevo's mipletamig shows promising results in AML treatment, Ethema Health appoints new CFO, and Sigyn Therapeutics introduces CardioDialysis for cardiovascular disease. Exciting advancements in cancer immunotherapy are also highlighted.

Lantern Pharma's FDA-approved STAR-001 trial targets pediatric CNS cancer, Catalyst Crew Tech launches CardioAI for cardiovascular risk assessment, and RHON-KLINIKUM AG achieves solid financial results in 2025.

Soligenix obtains 10-year exclusivity in EU for Behcet Disease treatment, following positive Phase 2a data, enhancing its rare autoimmune condition focus.

Oragenics discloses audit opinion, Lexaria Bioscience adds 5 new patents, NeuroOne® completes successful limited release of nerve ablation system, and Okogen Inc. acquires intellectual property for ranpirnase to expand ophthalmic program.

HeartBeam collaborates with Mount Sinai to advance AI-ECG technology, proton therapy shows promising results in cancer treatment, Soligenix prepares for key clinical milestones, and Engle Services offers tips for AC breakdowns in Alabama.

VolitionRx shows promising results in early cancer detection, GeoVax Labs progresses towards Phase 3 trial, and AccuRoute and InterFAX offer secure healthcare solutions for regulated industries.

Lantern Pharma and American Shared Hospital Services to discuss financial results; breakthrough discovery supports CardioDialysis for neuroinflammatory diseases; Catalyst Crew Technologies expands into Venezuela for healthcare tech initiatives.

Viromed Medical AG secures funding for cold plasma technology, Soligenix advances rare disease therapies, LIXTE Biotechnology targets cancer treatment improvement, and orthodontic practices offer cutting-edge care.

Jodi Ungrodt, a seasoned financial leader and SEC-Qualified Financial Expert, brings valuable expertise to BioStem Technologies as the new Chair of the Audit Committee. Meanwhile, global tributes honor the legacy of martial arts legend Chuck Norris, highlighting his profound impact on performance and conditioning in the sports nutrition industry.

Co-Diagnostics broadens distribution, while studies reveal links between lifestyle and health outcomes. Soligenix strengthens rare disease pipeline, and innovative therapies in cancer care and oncology are on the rise.

Vesicor Therapeutics appoints Dr. Michael Tolentino as CEO, while founder Dr. Luo Feng becomes CSO. Catalyst Crew Technologies seeks name change to LataMed AI Corp. to reflect focus on AI healthcare tech in Latin America.

Join MEDICLIN's virtual press conference, learn about Soligenix's HyBryte therapy, orthodontic care options in NC and NH, new research on reducing hypertensive disorders in pregnant women, and updates from Aditxt Inc. and Annovis Bio Inc.

Aclarion adopts stockholder rights plan; Soligenix focuses on HyBryte study and rare diseases; NRx Pharmaceuticals schedules conference call; Catalyst Crew introduces AI healthcare analytics platform for Latin America.

Lions Clubs International Foundation awards a grant to expand an eye bank, ETST integrates telehealth services, Rochester housing market prepares for medical influx, a study reveals insights on colorectal cancer, and Soligenix advances rare disease treatments through platform science.

Nutriband, VolitionRx, SS Innovations, Dr. Badia, and research findings on prediabetes and heart failure risks are spotlighted, alongside updates from NRx Pharmaceuticals and Oragenics Inc.

A new study shows promise in cancer treatment using mirror-image amino acids, while a report highlights a 90% failure rate in AI agent security in healthcare. Companies are advancing cancer therapies, but healthcare faces significant risks from unmonitored AI agents.

Scinai faces Nasdaq bid price issue; NeuroOne's OneRF technology aids epilepsy patients; Aclarion discusses Nociscan at ROTH Conference; Okuda Orthodontics offers Invisalign and brace options for all ages in Henderson, NV.

Sartorius introduces Eveo Cell Therapy Platform to boost production; Helix BioPharma faces financial challenges; BioUtah celebrates winners of life sciences pitch competition; HeartBeam revolutionizes cardiac monitoring; LIXTE Biotechnology and Liora Technologies partner to enhance cancer treatment.

Stacey Eisenberg emphasizes community effort in dementia care, Lifespring Chiropractic focuses on natural health education, and Voyageur Pharmaceuticals advances diagnostic imaging supply chain. Aubrey Schwartze wins sports scholarship. Friendly Recovery Center compares therapy options.

Dr. Kixx Goldman questions the impact of labeling in therapy, while attorney Willard Bakeman challenges America's justice system in two new books.

HeartBeam progresses post-FDA clearance, Sigyn Therapeutics explores merger options, gut microbiota's role in cancer treatment, Aditxt's acquisition in oncology, and LIXTE Biotechnology expands cancer trial partnerships.